哈斯达尔·米地里别克,张雷,巧丽番·阿力哈孜,木胡牙提,刘志强,何鹏义,杨玉春,居勒德孜·海拉提

• 1:新疆医科大学第一附属医院综合心脏内科

摘要(Abstract)：

目的探讨新疆地区哈萨克族无糖尿病人群空腹血糖(FPG)水平与冠状动脉病变严重程度的关系。方法纳入哈萨克族因高度疑诊冠心病行冠状动脉造影且既往无糖尿病的患者411例,根据冠状动脉造影将所有患者分为冠心病组(280例)和非冠心病组(131例)。冠状动脉病变严重程度以Gensini评分表示。根据FPG水平将所有研究对象分为4组[组1(FPG<5.6 mmol/L)、组2(5.6 mmol/L≤FPG<6.1 mmol/L)、组3(6.1 mmol/L≤FPG<7.0 mmol/L)、组4(FPG≥7.0 mmol/L)]。对患者生化指标、一般临床资料、冠状动脉造影资料进行比较,探讨与冠状动脉病变严重程度相关的危险因素。结果非冠心病组患者年龄[(55.05±10.32)岁比(59.00±10.11)岁,P<0.001]、男性(67.2%比77.1%,P=0.032)、吸烟史(38.2%比59.3%,P<0.001)、体重指数(BMI)[(22.96±1.62)kg/m2比(23.37±1.50)kg/m2,P=0.012]、高血压病(45.8%比62.1%,P=0.002)、FPG[(5.11±1.17)mmol/L比(6.34±2.51)mmol/L,P<0.001]、总胆固醇(TC)[(4.14±0.82)mmol/L比(3.95±0.96)mmol/L,P=0.040]、Gensini评分[(0.27±0.69)分比(36.63±33.88)分,P<0.001]均低于冠心病组,差异均有统计学意义;非冠心病组高密度脂蛋白胆固醇(HDL-C)[(1.13±0.28)mmol/L比(1.06±0.31)mmol/L,P=0.038]高于冠心病组,差异有统计学意义。组1、组2、组3及组4四组患者糖化血红蛋白(Hb A1c)[(2.17±0.33)mmol/L比(2.16±0.27)mmol/L比(2.30±0.28)mmol/L比(2.51±0.59)mmol/L,P<0.001]、三酰甘油(TG)[(1.67±1.60)mmol/L比(1.85±1.21)mmol/L比(2.08±1.34)mmol/L比(2.23±1.51)mmol/L,P=0.026]、低密度脂蛋白胆固醇(LDL-C)[(2.59±0.80)mmol/L比(2.71±0.81)mmol/L比(2.66±0.86)mmol/L比(2.35±0.74)mmol/L,P=0.040]和HDL-C[(1.13±0.30)mmol/L比(1.00±0.31)mmol/L比(1.07±0.29)mmol/L比(0.99±0.29)mmol/L,P<0.001]比较,差异均有统计学意义。患者FPG与Gensini评分Pearson相关性分析显示,两者明显相关(r=0.236,P<0.001),Gensini评分随着FPG浓度的增加而逐渐增加;多因素logistic回归分析发现,FPG(OR 1.53,95%CI 1.25~1.87,P<0.001)、年龄(OR 1.05,95%CI 1.02~1.08,P<0.001)、BMI(OR 1.20,95%CI 1.03~1.39,P=0.020)、吸烟史(OR 2.87,95%CI 1.61~5.10,P<0.001)及高血压病(OR 1.64,95%CI 1.02~2.64,P=0.041)均是冠心病相关的危险因素;多元线性回归分析显示,冠状动脉病变严重程度(Gensini评分)与FPG、年龄及吸烟呈正相关,与HDL-C浓度呈负相关。结论新疆地区哈萨克族无糖尿病人群的FPG与冠心病发生以及冠状动脉病变严重程度相关。

关键词(KeyWords)： 空腹血糖;冠心病;冠状动脉造影

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 哈斯达尔·米地里别克,张雷,巧丽番·阿力哈孜,木胡牙提,刘志强,何鹏义,杨玉春,居勒德孜·海拉提

参考文献(References)：

• [1]GBD 2013 Mortality and Causes of Death Collaborators.Global,regional,and national age-sex specifi c all-cause and cause-specifi c mortality for 240 causes of death,1990-2013:a systematic analysis for the Global Burden of Disease Study 2013.Lancet,2015,385(9963):117-171.
• [2]中华医学会心血管病学分会.中国心血管病预防指南.中华心血管病杂志,2011,39(1):3-22.
• [3]Arnold SV,Lipska KJ,Li Y,et al.The reliability and prognosis of in-hospital diagnosis of metabolic syndrome in the setting of acute myocardial infarction.J Am Coll Cardiol,2013,62(8):704-708.
• [4]Daly CA,Hildebrandt P,Bertrand M,et al.Adverse prognosis associated with the metabolic syndrome in established coronary artery disease:data from the EUROPA trial.Heart,2007,93(11):1406-1411.
• [5]Younis A,Tzur B,Peled Y,et al.Metabolic syndrome is independently associated with increased 20-year mortality in patients with stable coronary artery disease.Cardiovasc Diabetol,2016,15(1):149.
• [6]Gao Y,Lu B,Sun ML,et al.Comparison of atherosclerotic plaque by computed tomography angiography in patients with and without diabetes mellitus and with known or suspected coronary artery disease.Am J Cardiol,2011,108(6):809-813.
• [7]Gensini GG.A more meaningful scoring system for determining the severity of coronary heart disease.Am J Cardiol,1983,51(3):606.
• [8]Diagnosis and classifi cation of diabetes mellitus.Diabetes Care,2014,37 Suppl 1:S81-S90.
• [9]Burgess SN,Mussap CJ,French JK.Management of acute coronary syndromes in patients with diabetes:implications of the FREEDOM trial.Clin Ther,2013,35(8):1069-1075.
• [10]Hu FB,Stampfer MJ,Haff ner SM,et al.Elevated risk of cardiovascular disease prior to clinical diagnosis of type 2diabetes.Diabetes Care,2002,25(7):1129-1134.
• [11]Lorbeer R,Empen K,Dorr M,et al.Association between glycosylated haemoglobin A(1c)and endothelial function in an adult non-diabetic population.Atherosclerosis,2011,217(2):358-363.
• [12]Deedwania PC.Mechanisms of endothelial dysfunction in the metabolic syndrome.Curr Diab Rep,2003,3(4):289-292.
• [13]Sevinc Ok,Asci G,Kircelli F,et al.Relationship between glucose exposure via peritoneal dialysis solutions and coronary artery calcifi cation in non-diabetic peritoneal dialysis patients.Int Urol Nephrol,2012,44(6):1847-1853.
• [14]Levi M,van der Poll T,Schultz M.Infection and infl ammation as risk factors for thrombosis and atherosclerosis.Semin Thromb Hemost,2012,38(5):506-514.
• [15]Schinner S,Füth R,Kempf K,et al.A progressive increase in cardiovascular risk assessed by coronary angiography in non-diabetic patients at sub-diabetic glucose levels.Cardiovasc Diabetol,2011,10:56.
• [16]Ayhan H,Durmaz T,Keles T,et al.The relationship between acute coronary syndrome and stress hyperglycemia.Exp Clin Endocrinol Diabetes,2014,122(4):222-226.
• [17]Chen PC,Chua SK,Hung HF,et al.Admission hyperglycemia predicts poorer short-and long-term outcomes af ter primary percutaneous coronary intervention for ST-elevation myocardial infarction.J Diabetes Investig,2014,5(1):80-86.
• [18]Planer D,Witzenbichler B,Guagliumi G,et al.Impact of hyperglycemia in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention:the HORIZONS-AMI trial.Int J Cardiol,2013,167(6):2572-2579.
• [19]Gui MH,Qin GY,Ning G,et al.The comparison of coronary angiographic profi les between diabetic and nondiabetic patients with coronary artery disease in a Chinese population.Diabetes Res Clin Pract,2009,85(2):213-219.